In this issue:
Effects of methotrexate and biologics on depression and anxiety in psoriasis
Lymphoproliferative disorders and skin cancers with biologics
Acne in Japanese patients with atopic dermatitis receiving upadacitinib
Integrated safety analysis on skin cancers with ixekizumab
Dupilumab for bullous pemphigoid
Risankizumab for moderate-to-severe psoriasis
Interleukin-17A-correlated myocarditis in psoriasis
Dupilumab for prurigo nodularis
Please login below to download this issue (PDF)